EP2155148A2 - Tensidfreie schaumformulierungen - Google Patents
Tensidfreie schaumformulierungenInfo
- Publication number
- EP2155148A2 EP2155148A2 EP08759493A EP08759493A EP2155148A2 EP 2155148 A2 EP2155148 A2 EP 2155148A2 EP 08759493 A EP08759493 A EP 08759493A EP 08759493 A EP08759493 A EP 08759493A EP 2155148 A2 EP2155148 A2 EP 2155148A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- foam formulation
- emulsion
- formulation according
- pickering emulsion
- foam
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 95
- 239000006260 foam Substances 0.000 title claims abstract description 90
- 238000009472 formulation Methods 0.000 title claims abstract description 69
- 239000000839 emulsion Substances 0.000 claims abstract description 116
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 43
- 238000011049 filling Methods 0.000 claims abstract description 7
- 239000003995 emulsifying agent Substances 0.000 claims description 61
- 239000003921 oil Substances 0.000 claims description 32
- 239000003380 propellant Substances 0.000 claims description 27
- 239000007787 solid Substances 0.000 claims description 25
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 17
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 17
- 239000004480 active ingredient Substances 0.000 claims description 17
- 239000000126 substance Substances 0.000 claims description 16
- -1 Veegum Chemical compound 0.000 claims description 15
- 239000002562 thickening agent Substances 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 12
- 239000002537 cosmetic Substances 0.000 claims description 11
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 11
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 11
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 11
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 10
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 10
- 239000000194 fatty acid Substances 0.000 claims description 10
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 9
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 8
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 8
- 229930195729 fatty acid Natural products 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 239000004408 titanium dioxide Substances 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 6
- 235000011187 glycerol Nutrition 0.000 claims description 6
- 229920000642 polymer Polymers 0.000 claims description 6
- 150000004665 fatty acids Chemical class 0.000 claims description 5
- 150000002191 fatty alcohols Chemical class 0.000 claims description 5
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 5
- 239000011787 zinc oxide Substances 0.000 claims description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- 240000001432 Calendula officinalis Species 0.000 claims description 4
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 claims description 4
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims description 4
- 239000004202 carbamide Substances 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 229960002446 octanoic acid Drugs 0.000 claims description 4
- 229940101267 panthenol Drugs 0.000 claims description 4
- 235000020957 pantothenol Nutrition 0.000 claims description 4
- 239000011619 pantothenol Substances 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 239000000725 suspension Substances 0.000 claims description 4
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 3
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 claims description 3
- 235000003880 Calendula Nutrition 0.000 claims description 3
- 229920002674 hyaluronan Polymers 0.000 claims description 3
- 229960003160 hyaluronic acid Drugs 0.000 claims description 3
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 239000000377 silicon dioxide Substances 0.000 claims description 3
- 235000012239 silicon dioxide Nutrition 0.000 claims description 3
- 239000000516 sunscreening agent Substances 0.000 claims description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 2
- 241001116389 Aloe Species 0.000 claims description 2
- 241000086254 Arnica montana Species 0.000 claims description 2
- 235000018185 Betula X alpestris Nutrition 0.000 claims description 2
- 235000018212 Betula X uliginosa Nutrition 0.000 claims description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- 235000009024 Ceanothus sanguineus Nutrition 0.000 claims description 2
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims description 2
- 102000008186 Collagen Human genes 0.000 claims description 2
- 108010035532 Collagen Proteins 0.000 claims description 2
- 241000195493 Cryptophyta Species 0.000 claims description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- 102000016942 Elastin Human genes 0.000 claims description 2
- 108010014258 Elastin Proteins 0.000 claims description 2
- 241000196324 Embryophyta Species 0.000 claims description 2
- 241000195955 Equisetum hyemale Species 0.000 claims description 2
- 239000001856 Ethyl cellulose Substances 0.000 claims description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 2
- 241000208680 Hamamelis mollis Species 0.000 claims description 2
- 240000008669 Hedera helix Species 0.000 claims description 2
- 244000025221 Humulus lupulus Species 0.000 claims description 2
- 235000008694 Humulus lupulus Nutrition 0.000 claims description 2
- 240000007049 Juglans regia Species 0.000 claims description 2
- 235000009496 Juglans regia Nutrition 0.000 claims description 2
- 229940124091 Keratolytic Drugs 0.000 claims description 2
- 244000208060 Lawsonia inermis Species 0.000 claims description 2
- 240000003553 Leptospermum scoparium Species 0.000 claims description 2
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 2
- 244000042664 Matricaria chamomilla Species 0.000 claims description 2
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims description 2
- 244000246386 Mentha pulegium Species 0.000 claims description 2
- 235000016257 Mentha pulegium Nutrition 0.000 claims description 2
- 235000004357 Mentha x piperita Nutrition 0.000 claims description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 2
- 239000004793 Polystyrene Substances 0.000 claims description 2
- 235000016976 Quercus macrolepis Nutrition 0.000 claims description 2
- 244000305267 Quercus macrolepis Species 0.000 claims description 2
- 244000178231 Rosmarinus officinalis Species 0.000 claims description 2
- 240000000353 Ruscus aculeatus Species 0.000 claims description 2
- 235000003500 Ruscus aculeatus Nutrition 0.000 claims description 2
- 240000002299 Symphytum officinale Species 0.000 claims description 2
- 235000005865 Symphytum officinale Nutrition 0.000 claims description 2
- 244000269722 Thea sinensis Species 0.000 claims description 2
- 240000002657 Thymus vulgaris Species 0.000 claims description 2
- 235000007303 Thymus vulgaris Nutrition 0.000 claims description 2
- 244000274883 Urtica dioica Species 0.000 claims description 2
- 235000009108 Urtica dioica Nutrition 0.000 claims description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 2
- 229930003268 Vitamin C Natural products 0.000 claims description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 2
- 235000011399 aloe vera Nutrition 0.000 claims description 2
- 229940087168 alpha tocopherol Drugs 0.000 claims description 2
- 229940035676 analgesics Drugs 0.000 claims description 2
- 239000000730 antalgic agent Substances 0.000 claims description 2
- 239000003242 anti bacterial agent Substances 0.000 claims description 2
- 230000002682 anti-psoriatic effect Effects 0.000 claims description 2
- 239000000043 antiallergic agent Substances 0.000 claims description 2
- 229940088710 antibiotic agent Drugs 0.000 claims description 2
- 239000003096 antiparasitic agent Substances 0.000 claims description 2
- 239000003435 antirheumatic agent Substances 0.000 claims description 2
- 239000003443 antiviral agent Substances 0.000 claims description 2
- 229940121357 antivirals Drugs 0.000 claims description 2
- 239000000440 bentonite Substances 0.000 claims description 2
- 229910000278 bentonite Inorganic materials 0.000 claims description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 229940106189 ceramide Drugs 0.000 claims description 2
- 150000001783 ceramides Chemical class 0.000 claims description 2
- 229920001436 collagen Polymers 0.000 claims description 2
- 239000000824 cytostatic agent Substances 0.000 claims description 2
- 230000001085 cytostatic effect Effects 0.000 claims description 2
- 229940079919 digestives enzyme preparation Drugs 0.000 claims description 2
- GXGAKHNRMVGRPK-UHFFFAOYSA-N dimagnesium;dioxido-bis[[oxido(oxo)silyl]oxy]silane Chemical compound [Mg+2].[Mg+2].[O-][Si](=O)O[Si]([O-])([O-])O[Si]([O-])=O GXGAKHNRMVGRPK-UHFFFAOYSA-N 0.000 claims description 2
- 229920002549 elastin Polymers 0.000 claims description 2
- 229920001249 ethyl cellulose Polymers 0.000 claims description 2
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 2
- 239000003862 glucocorticoid Substances 0.000 claims description 2
- 235000009569 green tea Nutrition 0.000 claims description 2
- 239000003102 growth factor Substances 0.000 claims description 2
- 239000005556 hormone Substances 0.000 claims description 2
- 229940088597 hormone Drugs 0.000 claims description 2
- 235000001050 hortel pimenta Nutrition 0.000 claims description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 2
- 239000002917 insecticide Substances 0.000 claims description 2
- 230000001530 keratinolytic effect Effects 0.000 claims description 2
- 239000003410 keratolytic agent Substances 0.000 claims description 2
- 239000004310 lactic acid Substances 0.000 claims description 2
- 235000014655 lactic acid Nutrition 0.000 claims description 2
- 229920000126 latex Polymers 0.000 claims description 2
- 239000003589 local anesthetic agent Substances 0.000 claims description 2
- 229960005015 local anesthetics Drugs 0.000 claims description 2
- 239000000395 magnesium oxide Substances 0.000 claims description 2
- 239000000391 magnesium silicate Substances 0.000 claims description 2
- 229940099273 magnesium trisilicate Drugs 0.000 claims description 2
- 229910000386 magnesium trisilicate Inorganic materials 0.000 claims description 2
- 235000019793 magnesium trisilicate Nutrition 0.000 claims description 2
- 235000001968 nicotinic acid Nutrition 0.000 claims description 2
- 229960003512 nicotinic acid Drugs 0.000 claims description 2
- 239000011664 nicotinic acid Substances 0.000 claims description 2
- 150000002823 nitrates Chemical class 0.000 claims description 2
- 150000002828 nitro derivatives Chemical class 0.000 claims description 2
- 229940068065 phytosterols Drugs 0.000 claims description 2
- 239000000419 plant extract Substances 0.000 claims description 2
- 229920000193 polymethacrylate Polymers 0.000 claims description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 2
- 235000013824 polyphenols Nutrition 0.000 claims description 2
- 229920002223 polystyrene Polymers 0.000 claims description 2
- 229940088417 precipitated calcium carbonate Drugs 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- 235000002020 sage Nutrition 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 235000010356 sorbitol Nutrition 0.000 claims description 2
- 230000000475 sunscreen effect Effects 0.000 claims description 2
- 229940037128 systemic glucocorticoids Drugs 0.000 claims description 2
- 239000001585 thymus vulgaris Substances 0.000 claims description 2
- 229960000984 tocofersolan Drugs 0.000 claims description 2
- 235000019155 vitamin A Nutrition 0.000 claims description 2
- 239000011719 vitamin A Substances 0.000 claims description 2
- 235000019154 vitamin C Nutrition 0.000 claims description 2
- 239000011718 vitamin C Substances 0.000 claims description 2
- 229940045997 vitamin a Drugs 0.000 claims description 2
- 235000020234 walnut Nutrition 0.000 claims description 2
- 229940118846 witch hazel Drugs 0.000 claims description 2
- 239000002076 α-tocopherol Substances 0.000 claims description 2
- 235000004835 α-tocopherol Nutrition 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims 2
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 claims 1
- 235000005881 Calendula officinalis Nutrition 0.000 claims 1
- 230000003266 anti-allergic effect Effects 0.000 claims 1
- 229940124599 anti-inflammatory drug Drugs 0.000 claims 1
- 239000003599 detergent Substances 0.000 claims 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 229940127554 medical product Drugs 0.000 claims 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 claims 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 claims 1
- 230000029663 wound healing Effects 0.000 claims 1
- 230000001804 emulsifying effect Effects 0.000 abstract 1
- 239000007789 gas Substances 0.000 description 27
- 235000019198 oils Nutrition 0.000 description 26
- 238000002360 preparation method Methods 0.000 description 13
- 239000006071 cream Substances 0.000 description 8
- 229960003943 hypromellose Drugs 0.000 description 8
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 6
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- 239000000230 xanthan gum Substances 0.000 description 5
- 229920001285 xanthan gum Polymers 0.000 description 5
- 235000010493 xanthan gum Nutrition 0.000 description 5
- 229940082509 xanthan gum Drugs 0.000 description 5
- 235000019489 Almond oil Nutrition 0.000 description 4
- 239000013543 active substance Substances 0.000 description 4
- 239000008168 almond oil Substances 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 125000002091 cationic group Chemical group 0.000 description 3
- 238000005187 foaming Methods 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 230000005501 phase interface Effects 0.000 description 3
- 235000013772 propylene glycol Nutrition 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000004904 UV filter Substances 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 229920003086 cellulose ether Polymers 0.000 description 2
- 238000004581 coalescence Methods 0.000 description 2
- 239000008271 cosmetic emulsion Substances 0.000 description 2
- AMTWCFIAVKBGOD-UHFFFAOYSA-N dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane Chemical compound O=[Si]=O.CO[Si](C)(C)O[Si](C)(C)C AMTWCFIAVKBGOD-UHFFFAOYSA-N 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Chemical group CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 150000002334 glycols Chemical class 0.000 description 2
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 239000000693 micelle Substances 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 239000007764 o/w emulsion Substances 0.000 description 2
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 2
- 229920000223 polyglycerol Polymers 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 229940083037 simethicone Drugs 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- JGPIWNNFLKDTSR-UHFFFAOYSA-N 2-(2-oxopyrrolidin-1-yl)acetic acid Chemical compound OC(=O)CN1CCCC1=O JGPIWNNFLKDTSR-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 208000035985 Body Odor Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229940123907 Disease modifying antirheumatic drug Drugs 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 229920002449 FKM Polymers 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 206010040904 Skin odour abnormal Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- 150000003868 ammonium compounds Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000012874 anionic emulsifier Substances 0.000 description 1
- 230000001857 anti-mycotic effect Effects 0.000 description 1
- 230000002141 anti-parasite Effects 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000002543 antimycotic Substances 0.000 description 1
- 229940125687 antiparasitic agent Drugs 0.000 description 1
- 229940030999 antipsoriatics Drugs 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical class OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 150000001983 dialkylethers Chemical class 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 229940126534 drug product Drugs 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 238000007046 ethoxylation reaction Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000004872 foam stabilizing agent Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 230000000544 hyperemic effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000004611 light stabiliser Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000008251 pharmaceutical emulsion Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 230000009993 protective function Effects 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000003357 wound healing promoting agent Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/046—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/29—Titanium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/124—Aerosols; Foams characterised by the propellant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
- A61K2800/33—Free of surfactant
Definitions
- the present invention relates to cosmetic and dermatological
- the invention relates to the use of Pickering emulsions for the production of foams.
- Emulsion is generally understood to mean heterogeneous systems which consist of two liquids which are immiscible or only slightly miscible with one another, which are usually referred to as phases.
- one of the two liquids is dispersed in the form of very fine droplets in the other liquid.
- the two liquids are water and oil and oil droplets are finely dispersed in water, then it is an oil-in-water emulsion (O / W emulsion, for example, milk).
- O / W emulsion for example, milk
- the basic character of an O / W emulsion is characterized by the water.
- a water-in-oil emulsion (W / O emulsion, e.g., butter) is the reverse principle, with the basic character here being determined by the oil.
- Emulsifiers In order to achieve the permanent dispersion of one liquid in another, emulsions in the conventional sense require the addition of a surface-active substance (emulsifier).
- Emulsifiers have an amphiphilic molecular structure consisting of a polar (hydrophilic) and a nonpolar (lipophilic) moiety, which are spatially separated.
- emulsifier enclosed droplets of the second phase water droplets in W / O or lipid vesicles in O / W emulsions
- Emulsifiers reduce the interfacial tension between the phases by being located at the interface between the two liquids. They form interface surfaces at the oil / water phase interface, which counteracts irreversible coalescence of the droplets.
- Emulsifier mixtures are often used to stabilize emulsions.
- emulsifier or "conventional emulsifier” is known in the art. Conventional emulsifiers and their use are described, for example, in the publications: Vietnamesekosmetik, 4th edition,ticianliche Verlagsgesellschaft mbH Stuttgart, pages 151 to 159, and Fiedler Lexikon der Hilfsstoffe, 5th edition Editio Cantor Verlag Aulendorf, pages 97 to 121 described.
- emulsifiers can be broken down into ionic (anionic, cationic and amphoteric) and nonionic according to their hydrophilic moiety:
- an anionic emulsifier is the soap, usually referred to as the water-soluble sodium or potassium salts of the saturated and unsaturated higher fatty acids.
- hydrophilic part of the molecule of nonionic emulsifiers often consists of glycerol, polyglycerol, sorbitans, carbohydrates or
- Emulsions represent an important product type in the field of cosmetic and / or dermatological preparations, which is used in the most diverse fields of application.
- a variety of products - such as lotions and creams - are available for the care of the skin, in particular for the refatting of dry skin.
- the aim of skin care is to compensate for the loss of fat and water caused by daily washing of the skin.
- skin care products should protect against environmental influences - especially from sun and wind - and delay the aging of the skin.
- Cosmetic emulsions are also used as deodorants. Such formulations serve to eliminate body odor that results when the odorless fresh sweat is decomposed by microorganisms.
- emulsions in the form of cleaning emulsions use. They are mostly used for facial cleansing and in particular for removing decorative cosmetics.
- Cleaning emulsions have - in contrast to other cleaning preparations such as soap - the advantage of being particularly tolerated by the skin, as they may contain nourishing oils and / or non-polar active substances such as vitamin E in their lipophilic phase.
- emulsifier-free emulsions are emulsifier-free emulsions. These are free of emulsifiers in the strict sense, i. of low molecular weight amphiphilic substances (molecular weight ⁇ 5000) which can form micelles and / or other liquid crystalline aggregates in higher concentrations.
- emulsifier is to be understood here as customary in the art: IUPAC defines the properties of an emulsifier as follows: Emulsifiers are surface-active substances which preferentially adhere to the interface between the oil and water phases and thus reduce the interfacial tension In addition, these substances are able to improve the stability of emulsions by reducing the rate of aggregation and / or coalescence.
- emulsifiers for the stabilization of pharmaceutical and cosmetic emulsions predominantly so-called genuine emulsifiers, ie conventional emulsifiers in the sense of the present description, are used, which according to their structure and their physicochemical behavior belong to the substance class of the surfactants. They are characterized by an amphiphilic structure and the ability to micellar association.
- emulsifier-free has also been established in the field of medicine, according to a definition of the concept adopted by the Society for Dermopharmacy in an interdisciplinary consensus between pharmacists, dermatologists and other experts (http://www.dermotopics.de/de/ausgabe_ 1 _03_e / emulgatorok_ 1 _2003_d.
- emulsifier-free if it is stabilized with surface-active macromolecules (molecular weight above 5000) instead of emulsifiers in the narrower sense (conventional emulsifiers).
- a special form of the emulsifier-free emulsion is the Pickering emulsion.
- Pickering / solids-stabilized emulsions are stabilized by finely divided solid particles and make it possible to dispense with conventional emulsifiers as far as possible.
- the solid substance In Pickering emulsions, the solid substance accumulates at the phase interface oil / water in the form of a layer, which prevents the disperse phases from flowing together. Of particular importance in this case are the wetting properties of the solid particles, which should be wetted by both hydrophilic and lipophilic phases.
- a particular application of cosmetic and / or dermatological emulsions is the application as foams.
- Foam formulations have the
- Foams are complicated physical structures that require special tuning of the foam-forming components.
- Foams are generally obtained by spraying an emulsion formulation or an aqueous surfactant (stabilizer) solution.
- the propellant-added emulsion is discharged from a pressurized container (such systems are also referred to in the literature and patent literature as aerosol foams).
- the pressurized mixture of emulsion and propellant gas expands and forms the foam bubbles.
- foams can also be produced using other systems, such as pump sprays.
- Coordinated foam formulations have a stable two- or more-phase polydisperse structure on application which forms a network structure on the skin comparable to a membrane.
- Such network structures have the advantage that they form a protective function, for example before contact with water, but allow unimpeded gas exchange with the environment. In such foams, there is virtually no obstruction of Perspiratio insensibiles and no corresponding heat accumulation. Thus, the positive properties of a protective and care function are associated with an unchanged skin respiration.
- Foam formulations known heretofore include conventional surfactants / emulsifiers which provide for the stabilization of the emulsion and for the subsequent foam stability.
- WO 2004/017930 describes further Pickering emulsions, which are distinguished, in particular, by a low viscosity and are thus suitable for dermatological wipes. Such low viscosity Pickering emulsions can even be sprayed under mist formation.
- foam formulations associated with those of the Pickering emulsions can be prepared without conventional emulsifiers or with very low levels of conventional emulsifiers, which combine the positive properties of the foam, namely the physical structure and pleasant applicability, with good skin tolerance. This combination of properties makes such foam formulation particularly useful for cosmetic and dermatological formulations for sensitive skin types. It Compatibility and ease of use are advantageously combined.
- Foam products leads.
- foams are obtained, for example, by incorporating propellant gases in O / W emulsion systems. If the propellant gas dissolved in the dispersed oil phase evaporates during foaming, a foam forms (gas in liquid dispersion). Upon evaporation or expansion of the propellant gas dissolved in the disperse oil phase, dilatation of the dispersed oil phase occurs. It is now surprising that the solids network at the phase interface of this strain load withstands and it does not break the preparation during foaming.
- the invention thus relates to foam formulations comprising a
- Pickering emulsion of the oil-in-water type comprising an oil phase and a water phase, and optionally propellant gas.
- the invention relates to foam formulations containing not more than 0.5% by weight of conventional emulsifiers, preferably not more than 0.3% by weight, more preferably not more than 0.1% by weight, and more preferably free from conventional emulsifiers.
- the levies are each related to the total weight of the emulsion without propellant gas.
- the invention relates to the use of Pickering emulsions, in particular Pickering emulsions, which are substantially free or free of conventional emulsifiers, for the production of foam formulations. Furthermore, the invention relates to the use of foam formulations based on Pickering emulsions as a carrier for active ingredients, as skin care agents, as skin cleansers or as sunscreen. The foam formulation can therefore be used as a cosmetic, medical device or pharmaceutical.
- the invention includes a process for the preparation of foam formulations based on Pickering emulsions.
- the method comprises the steps:
- foam formulations are formulations, in particular emulsions, which are prepared to produce foam.
- the formulations may either be filled with propellant gas into a pressure vessel or be bottled without propellant in a container other than a pressure vessel, which makes it possible, when dispensing the
- substantially emulsifier-free emulsions are those emulsions which are not more than 0.5% by weight, preferably not more than 0.3% by weight, more preferably not more than 0.1% by weight of conventional emulsifiers contain.
- emulsifier-free emulsions are those which contain no conventional emulsifiers.
- a Pickering emulsion is a solids-stabilized emulsion.
- it is a solids-stabilized emulsion of the oil-in-water type (O / W emulsion).
- a solids-stabilized emulsion according to the invention comprises not more than 0.5% by weight, preferably not more than 0.3% by weight, more preferably not more than 0.1% by weight of conventional emulsifiers.
- conventional emulsifiers according to the present invention are anionic, cationic, amphoteric and nonionic surfactants.
- anionic surfactants are neutralized branched and / or unbranched, saturated or unsaturated fatty acids having a chain length of 10 to 40 carbon atoms.
- Typical representatives of the cationic surfactants are
- Typical representatives of the nonionic surfactants have a hydrophilic moiety, such as glycerol, polyglycerol, sorbitan, carbohydrates or polyoxyethylene glycols, which is linked via ester and / or ether bonds with the lipophilic moiety, which usually consists of fatty alcohols, fatty acids or iso-fatty acids.
- the polyethoxylated fatty acid esters having chain lengths of 10 to 40 carbon atoms and having a degree of ethoxylation of 5 to 100 belong to this group.
- conventional emulsifiers for the purposes of the present application are all amphiphilic substances with a molecular weight ⁇ 5000, which in a higher concentration micelles and / or others
- conventional emulsifiers are all surface-active substances which, in particular at conventional storage and application temperatures, e.g. Room temperature is not present as a solid or polymer.
- a solid emulsifier is a particulate substance which is wettable by both lipophilic and hydrophilic liquids. These may be inorganic or organic solids. The particles may also be untreated or coated. The particle size is preferably between 1 nm and 200 nm, more preferably between 5 nm and 100 nm.
- Suitable solid emulsifiers are particulate inorganic or organic solids which are wettable by both lipophilic and hydrophilic liquids. Suitable representatives are, for example, titanium dioxide, in particular coated Titanium oxide (eg available from Merck KGaA under the name Eusolex® T-2000), zinc oxide (obtainable from BASF AG under the name Z-Cote Max) silicon dioxide, in particular highly disperse silicon dioxide, Fe 2 O 3 , Veegum, bentonite and ethylcellulose. Further, alumina, nanoparticulate precipitated calcium carbonate, carbon, magnesia, magnesium trisilicate, crystalline fatty alcohols and fatty acids, polymer latices, e.g. Polystyrenes or polymethacrylates, and polymer pseudolatices. Mixtures of the abovementioned solid emulsifiers can also be used. Coated titanium dioxide or zinc oxide are preferred.
- the emulsions according to the invention contain more than 1% by weight of solid emulsifier, preferably more than 2% by weight of solid emulsifier, in particular from 2 to 7% by weight of solid emulsifier.
- the emulsions according to the invention particularly preferably contain 3 to 4% by weight of the most solid ffemulgator. The data are in each case based on the total weight of the emulsion without propellant gas.
- Suitable components which can form the oil phase can be selected from the polar and non-polar oils or mixtures thereof.
- the oil phase of the inventive formulations is advantageously selected from the group of lecithins and fatty acid triglycerides, from the group of propylene glycols or butylene glycols, fatty acid esters, from the group of natural waxes of animal and vegetable origin, from the group of ester oils, from the group of dialkyl ethers and dialkyl carbonates, from the group of branched and unbranched hydrocarbons and waxes and from the group of cyclic and linear silicone oils.
- Particular preference is given to triglycerides, in particular caprylic / capric triglyceride, obtainable under the name Miglyol 812 from Sasol and its blending with further oil and wax components.
- triglycerides in particular caprylic / capric acid triglyceride, obtainable under the name Miglyol 812 from Sasol / Myritol 312 from Cognis.
- the emulsions according to the invention preferably contain from 10 to 50% by weight of oil phase, more preferably from 25 to 35% by weight of oil phase.
- the data are in each case based on the total weight of the emulsion without propellant gas.
- the water phase may contain cosmetic adjuvants, e.g. lower alcohols (e.g., ethanol, isopropanol), lower diols or polyols, and their ethers (e.g., propylene glycol, glycerin, butylene glycol, hexylene glycol, and ethylene glycol), foam stabilizers, and thickeners.
- cosmetic adjuvants e.g. lower alcohols (e.g., ethanol, isopropanol), lower diols or polyols, and their ethers (e.g., propylene glycol, glycerin, butylene glycol, hexylene glycol, and ethylene glycol), foam stabilizers, and thickeners.
- Suitable thickeners are polymeric thickeners which are partially water soluble or at least water dispersible and form gels or viscous solutions in aqueous systems. They increase the viscosity of the water either by binding water molecules (hydration) or by absorbing and enveloping the water in their intertwined macromolecules, thereby restricting the mobility of the water.
- Suitable polymers are:
- Modified natural substances such as cellulose ethers (eg hydroxypropyl cellulose ethers, hydroxyethyl cellulose and hydroxypropylmethyl cellulose ethers); Natural compounds such as agar-agar, carrageenan, polyoses, starch, dextrins, gelatin, casein;
- cellulose ethers eg hydroxypropyl cellulose ethers, hydroxyethyl cellulose and hydroxypropylmethyl cellulose ethers
- Natural compounds such as agar-agar, carrageenan, polyoses, starch, dextrins, gelatin, casein;
- Synthetic compounds e.g. Vinyl polymers, polyethers, polyimines, polyamides and derivatives of polyacrylic acid; and - inorganic compounds such as e.g. Polysilicic acid and clay minerals.
- a cellulose ether is included. Particular preference is given to hydroxypropylmethylcellulose.
- the emulsions according to the invention preferably contain from 0.2 to 1.5% by weight
- Thickener (based on the dry weight of the thickener and the total weight of the emulsion without propellant gas). Particularly preferred are 0.5 to 0.8 wt .-% thickener.
- the active ingredient contained can be chosen from among all surface-applied on the skin agents and mixtures thereof.
- the active ingredient may be cosmetic or pharmaceutical. Accordingly, one obtains cosmetic or dermatological (to be used as a medical device or drug product) foam formulations. Furthermore, the formulation can be used to protect the skin from environmental influences.
- the active substance can be purely vegetable or synthetic.
- the group of active ingredients may also overlap with the other ingredient groups, such as the oil component, the thickeners or the solids emulsifiers.
- some oil components can also serve as active ingredients, such as oils with polyunsaturated fatty acids, or solid emulsifiers, such as particulate titanium dioxide can serve as a UV filter.
- the substances can be assigned to several groups.
- Active ingredients of the formulations according to the invention are advantageously selected from the group of substances with moisturizing and barrier-strengthening properties, such as, for example, As hydro viton, a replica of NMF, Pyrrolidoncarbonklare and their salts, lactic acid and its salts, glycerol, sorbitol, propylene glycol and urea, substances from the group of proteins and protein hydrolysates such.
- As collagen, elastin and silk protein substances from the group of glucosaminoglucans, such as. B. hyaluronic acid, from the group of carbohydrates, such as.
- pentavidin which corresponds in composition to the carbohydrate mixture of the human horny layer, and the group of lipids and lipid precursors such as ceramides.
- Further advantageous agents may be further selected in the context of the present invention from the group of vitamins, such as. As panthenol, niacin, ⁇ -tocopherol and its esters, vitamin A and vitamin C.
- the active ingredients selected from the group of antioxidants z. G., Galate and polyphenols. Urea, hyaluronic acid and pentavitin are preferred substances.
- substances with skin calming and regenerating action are used as active ingredients, such as.
- active ingredients such as.
- Advantageous active ingredients in the context of the present invention are also plants and plant extracts. These include e.g. Algae, aloe, arnica, beard braid, comfrey, birch, nettle, calendula, oak, ivy, witch hazel, henna, hops, chamomile, butcher's broom, peppermint, calendula, rosemary, sage, green tea, tea tree, horsetail, thyme and walnut and their extracts.
- plants and plant extracts include e.g. Algae, aloe, arnica, beard braid, comfrey, birch, nettle, calendula, oak, ivy, witch hazel, henna, hops, chamomile, butcher's broom, peppermint, calendula, rosemary, sage, green tea, tea tree, horsetail, thyme and walnut and their extracts.
- the preparations according to the invention may also contain as active ingredients antimycotics and antiseptics / disinfinents of synthetic or natural origin.
- active ingredients are glucocorticoids, antibiotics, analgesics, antiphlogistics, antirheumatics, antiallergic drugs, antiparasitics, antipruriticosa, antipsoriatics, retinoids, local anesthetics, vein therapeutics, keratolytics, hyperemic substances, coronary therapeutics (nitrates / nitro compounds), antivirals, cytostatics, hormones, wound healing promoting agents, eg growth factors, enzyme preparations and insecticides.
- the formulations may include dyes, pearlescent pigments, fragrances / perfume,
- Light stabilizer substances preservatives, complexing agents, antioxidants and repellents.
- Suitable propellants are z. B. N 2 O, propane, butane and i-butane, the finished
- Foam formulation contains from 5 to 15 wt .-%, preferably about 10 wt .-% propellant gas.
- the foam formulations according to the invention are made by providing an oil-in-water type emulsion of Pickering and filling the emulsion or Pickering emulsion and optionally propellant gas into one optionally produced pressure vessel.
- the Pickeringemulsion can also be filled into another container, which is suitable even without propellant gas to deliver the Pickeringemulsion as a foam.
- the Pickering emulsion is prepared in the following steps:
- the oil phase and the water phase at a temperature of 50 to 90 0 C, preferably from 50 to 70 0 C and particularly preferably at about 60 0 C homogenized.
- the Pickering emulsion comprises a thickening agent
- the following steps are added: 5. Provide an aqueous thickener solution
- the Pickeringemulsion is applied with 10 wt .-% propellant gas for the preparation of the foam formulation. 4.
- the foam formulations of the present invention can be used for all cosmetic and dermatological (medical or pharmaceutical) purposes.
- the formulations could be used as a skin care or skin cleanser. They can also serve as carriers for active ingredients and be used in the medical dermatological field.
- the formulations can be used as sunscreen agents.
- Many of the solid emulsifiers, such as titanium dioxide, are effective UVA and UVB filters.
- composition of the primary Pickering emulsion Composition of the primary Pickering emulsion:
- composition of the foam formulation :
- Eusolex T2000 is weighed and transferred into a laboratory homogenizer and mixed with the heated to 60 0 C Miglyol 812 within one minute, and homogenized within 5 minutes.
- the water is heated to 60 ° C. and added at 1000 rpm for one minute.
- the mixture is homogenized at 3000 rpm for 5 minutes.
- hypromellose solution 30.00 g are added to 60.00 g of the primary Pickering emulsion with stirring.
- the hypromellose Pickeringemulsion is then applied in aluminum monoblock cans with 10.00 g of propellant gas.
- a stable, fine-bubble cream foam is formed when removing the foam formulation from the compressed gas package by means of a suitable valve with attached foam applicator.
- the structure of the cream foam is maintained for a period of time sufficient to evenly distribute the foam on the skin. 5.2.
- composition of the primary Pickering emulsion Composition of the primary Pickering emulsion:
- Myritol 318 from Cognis (caprylic acid / capric triglyceride) 30.00 g almond oil 100.00 g water
- composition of the xanthan gum solution (1%):
- composition of the foam formulation :
- Eusolex T 2000 is weighed and transferred into a laboratory homogenizer and mixed with the 0 to 60 C mixture of Cetiol V, Myritol 318 and almond oil within one minute and homogenized within 5 minutes.
- the water is heated to 60 ° C. and added at 1000 rpm for one minute.
- the mixture is homogenized at 3000 rpm for 5 minutes.
- Preparation of foam formulation 30.00 g of xanthan gum solution is added to 60.00 g of the primary Pickering emulsion with stirring.
- the xanthan gum solution-containing Pickeringemulsion is then applied in aluminum monoblock cans with 10.00 g of propellant gas.
- a stable, fine-bubble cream foam is formed when removing the foam formulation from the compressed gas package by means of a suitable valve with attached foam applicator.
- the structure of the cream foam is maintained for a period of time sufficient to evenly distribute the foam on the skin.
- composition of the primary Pickering emulsion Composition of the primary Pickering emulsion:
- ZCote is weighed and transferred to a laboratory homogenizer and mixed with the mixture of Cetiol V, Myritol 318, Cetiol SN and almond oil within one minute and homogenized within 5 minutes.
- the water is added at 1000 rpm within one minute.
- the mixture is homogenized at 3000 rpm for 5 minutes.
- hypromellose solution 52.00 g are added to 40.00 g of the primary Pickering emulsion with stirring.
- the hypromellose Pickeringemulsion is then applied in aluminum monoblock cans with 8.00 g of propellant gas.
- a stable, fine-bubble cream foam is formed when removing the foam formulation from the compressed gas package by means of a suitable valve with attached foam applicator.
- the structure of the cream foam is maintained for a period of time sufficient to evenly distribute the foam on the skin.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Colloid Chemistry (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Detergent Compositions (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08759493A EP2155148A2 (de) | 2007-05-10 | 2008-05-09 | Tensidfreie schaumformulierungen |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07107950A EP1992323B1 (de) | 2007-05-10 | 2007-05-10 | Tensidfreie Schaumformulierungen |
EP08759493A EP2155148A2 (de) | 2007-05-10 | 2008-05-09 | Tensidfreie schaumformulierungen |
PCT/EP2008/055760 WO2008138894A2 (de) | 2007-05-10 | 2008-05-09 | Tensidfreie schaumformulierungen |
Publications (1)
Publication Number | Publication Date |
---|---|
EP2155148A2 true EP2155148A2 (de) | 2010-02-24 |
Family
ID=38788222
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP07107950A Active EP1992323B1 (de) | 2007-05-10 | 2007-05-10 | Tensidfreie Schaumformulierungen |
EP08759493A Ceased EP2155148A2 (de) | 2007-05-10 | 2008-05-09 | Tensidfreie schaumformulierungen |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP07107950A Active EP1992323B1 (de) | 2007-05-10 | 2007-05-10 | Tensidfreie Schaumformulierungen |
Country Status (23)
Country | Link |
---|---|
US (4) | US20100316684A1 (de) |
EP (2) | EP1992323B1 (de) |
JP (1) | JP2010527332A (de) |
KR (1) | KR101604776B1 (de) |
CN (1) | CN101677913B (de) |
AT (1) | ATE544441T1 (de) |
AU (1) | AU2008250298B2 (de) |
CA (1) | CA2683869C (de) |
CO (1) | CO6361888A2 (de) |
DK (1) | DK1992323T3 (de) |
EA (1) | EA023887B1 (de) |
EC (1) | ECSP10010396A (de) |
ES (1) | ES2382110T3 (de) |
HK (1) | HK1126126A1 (de) |
HR (1) | HRP20120371T1 (de) |
IL (1) | IL201972A (de) |
MX (1) | MX2009011708A (de) |
PL (1) | PL1992323T3 (de) |
PT (1) | PT1992323E (de) |
RS (1) | RS52336B (de) |
UA (1) | UA98960C2 (de) |
WO (1) | WO2008138894A2 (de) |
ZA (1) | ZA200906927B (de) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
JP4994397B2 (ja) * | 2009-01-05 | 2012-08-08 | 富士フイルム株式会社 | アスタキサンチン含有分散物及びその製造方法 |
CN102300548A (zh) | 2009-01-29 | 2011-12-28 | 欧莱雅 | 处于泡沫形式的化妆品组合物 |
WO2011013009A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
US20110054058A1 (en) * | 2009-08-31 | 2011-03-03 | William Crooker | Emulsified polyol and resultant foam therefrom |
CA2683258C (en) * | 2009-10-20 | 2011-08-09 | Asa Bullion Investment Limited | Lotion for cleaning human anorectal area |
ES2537151T3 (es) * | 2009-12-10 | 2015-06-02 | Neubourg Skin Care Gmbh & Co. Kg | Formulaciones de espuma estabilizadas con polímeros, libres de emulsionantes |
PL2363108T3 (pl) | 2010-03-02 | 2018-04-30 | Neubourg Skin Care Gmbh & Co. Kg | Formulacje piankowe zawierające co najmniej jeden triterpenoid |
FR2962662B1 (fr) * | 2010-07-19 | 2012-08-24 | Agronomique Inst Nat Rech | Composition sous forme d'emulsion, comprenant une phase hydrophobe dispersee dans une phase aqueuse |
CA2819581C (en) * | 2010-12-15 | 2019-06-18 | Speximo Ab | New particle stabilized emulsions and foams |
CN102085162B (zh) * | 2011-01-13 | 2013-04-03 | 广州环亚化妆品科技有限公司 | 一种不含表面活性剂的洁面乳剂及其制备方法 |
CN102772318A (zh) * | 2011-05-09 | 2012-11-14 | 深圳市中航健身时尚股份有限公司 | 一种弱膜清洗型去角质组合物及其制造方法 |
DE202011100483U1 (de) | 2011-05-10 | 2011-07-13 | Neubourg Skin Care Gmbh & Co. Kg | Applikationssystem für Pflegeprodukte mit Schwammapplikator |
CN102488638A (zh) * | 2011-12-16 | 2012-06-13 | 江南大学 | 一种不添加或少添加乳化剂和防腐剂的化妆品 |
WO2014001033A1 (en) * | 2012-06-27 | 2014-01-03 | Unilever N.V. | Sheet-like particulates comprising an alkylated cellulose ether and method for making these |
KR101435161B1 (ko) * | 2012-08-17 | 2014-08-29 | 주식회사 엔에프씨 | 피부 세정용 화장료 조성물 및 이를 이용하여 제조된 계면활성제를 포함하지 않는 세안제 |
CN104812376A (zh) | 2012-09-27 | 2015-07-29 | Msd消费保健品公司 | 起泡的护肤制剂 |
KR102007800B1 (ko) | 2012-11-09 | 2019-08-07 | (주)아모레퍼시픽 | 무스형의 자외선 차단용 화장료 조성물 |
MX352379B (es) | 2013-04-05 | 2017-11-17 | Procter & Gamble | Composicion para el cuidado personal que comprende una formulacion preemulsionada. |
FR3008617B1 (fr) * | 2013-07-18 | 2016-09-23 | Oreal | Emulsions pickering huile/huile renfermant des particules a rupture de courbe, compositions les comprenant et utilisation des particules pour stabiliser des emulsions h/h de pickering |
EP3082711B1 (de) * | 2013-12-18 | 2021-09-08 | L'Oréal | Zusammensetzung aus einer pickering-emulsion mit geringen alkoholmengen |
DE102013114572A1 (de) * | 2013-12-19 | 2015-06-25 | Leibniz-Institut Für Neue Materialien Gemeinnützige Gmbh | Verfahren zur Herstellung strukturierter metallischer Beschichtungen |
EP2907823A1 (de) | 2014-02-14 | 2015-08-19 | Gene Signal International SA | Polypeptidfragmente von 168A-T2 und diese enthaltende Zusamensetzungen zur verwendung zur Behandlung von Krebs |
CN105979927B (zh) | 2014-02-21 | 2020-06-16 | 株式会社爱茉莉太平洋 | 具有耐水性的摩丝型化妆品组合物 |
CN104013955B (zh) * | 2014-06-18 | 2016-02-24 | 中国科学院过程工程研究所 | 一种不含表面活性剂的水包油乳液及其用途 |
KR101967565B1 (ko) * | 2014-09-25 | 2019-04-09 | 권옥선 | 환원 처리제, 환원 화장품, 및 환원 식품, 및 환원 처리제의 제조 방법 |
CN104233802B (zh) * | 2014-09-28 | 2016-06-22 | 苏州印丝特纺织数码科技有限公司 | 一种具有光子晶体结构色的蚕丝织物的制备方法 |
US10806688B2 (en) | 2014-10-03 | 2020-10-20 | The Procter And Gamble Company | Method of achieving improved volume and combability using an anti-dandruff personal care composition comprising a pre-emulsified formulation |
US9993404B2 (en) | 2015-01-15 | 2018-06-12 | The Procter & Gamble Company | Translucent hair conditioning composition |
KR101757245B1 (ko) | 2015-07-28 | 2017-07-13 | 한국과학기술원 | 피커링 에멀젼 및 그 제조 방법 |
US20170079892A1 (en) * | 2015-09-18 | 2017-03-23 | Johnson & Johnson Consumer Inc. | Foaming sunscreen composition containing an ultraviolet radiation-absorbing compound and a superhydrophilic amphiphilic copolymer |
JP6970094B2 (ja) | 2016-01-20 | 2021-11-24 | ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company | モノアルキルグリセリルエーテルを含むヘアコンディショニング組成物 |
CN106806162A (zh) * | 2016-02-13 | 2017-06-09 | 顾银凤 | 一种具有防衰老、美白、保湿功效的化妆品 |
CN107312179B (zh) * | 2016-04-26 | 2020-08-25 | 中国科学院理化技术研究所 | 烟草花叶病毒-聚(N-异丙基丙烯酰胺)嵌段共聚物Pickering乳液的制备方法 |
WO2018010094A1 (en) * | 2016-07-12 | 2018-01-18 | L'oreal | Composition of pickering emulsion |
MX2020012139A (es) | 2016-09-08 | 2021-01-29 | Vyne Pharmaceuticals Inc | Composiciones y metodos para tratar rosacea y acne. |
KR101971658B1 (ko) | 2016-10-20 | 2019-04-24 | 한국과학기술원 | 기공 표면에 입자가 부착된 다공성 고분자, 이의 제조방법 및 이의 용도 |
JP6884574B2 (ja) * | 2016-12-28 | 2021-06-09 | ポーラ化成工業株式会社 | 粉体粒子表面の改質方法 |
CN106731925A (zh) * | 2017-01-06 | 2017-05-31 | 宁波大学 | 固相分散辅助乳化方法 |
DE102017204709A1 (de) | 2017-03-21 | 2018-09-27 | Beiersdorf Ag | Kosmetischer Schaum enthaltend Wachse und Polyacrylsäurepolymere |
KR101981853B1 (ko) | 2017-06-19 | 2019-05-23 | 연세대학교 원주산학협력단 | 폴리이미드 입자를 이용한 피커링 에멀젼 조성물 및 이의 제조방법 |
CN107970230B (zh) * | 2017-11-10 | 2020-04-28 | 华南理工大学 | 一种能瓦解和抑制细菌生物被膜的生成的皮克林乳液及其制备和应用 |
WO2019239526A1 (ja) * | 2018-06-13 | 2019-12-19 | 三菱ケミカルフーズ株式会社 | 水中油型ピッカリングエマルション |
DE102018212458A1 (de) | 2018-07-26 | 2020-01-30 | Beiersdorf Ag | Mineralöl- und Emulgatorfreie Zubereitung |
JP6781358B1 (ja) * | 2018-12-19 | 2020-11-04 | 日東メディック株式会社 | 起泡性外用組成物 |
JP7429504B2 (ja) * | 2019-06-28 | 2024-02-08 | リンテック株式会社 | 噴射装置、組成物の噴射方法、及び、噴射用の組成物 |
CN110354027A (zh) * | 2019-08-28 | 2019-10-22 | 重庆医科大学 | 一种多功能乳液及其制备方法 |
CN111116975B (zh) * | 2019-12-30 | 2021-01-08 | 浙江大学 | 一种基于液滴相互吸引的Pickering乳液凝胶及其制备方法 |
CN111205479B (zh) * | 2020-01-14 | 2022-11-18 | 陕西师范大学 | 一种改性细菌纤维素纳米纤维稳定的高内相Pickering乳液及其制备方法 |
CN111296840B (zh) * | 2020-03-27 | 2022-08-23 | 重庆市中药研究院 | 一种具有调节胃肠道健康作用的姜枣合用乳液及其制备方法 |
EP4138785A1 (de) | 2020-04-21 | 2023-03-01 | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. | Feste dispersionen und partikel und verfahren zur kontrollierten freisetzung lipidlöslicher oder versenkbarer wirkstoffe |
US20230166229A1 (en) | 2020-05-14 | 2023-06-01 | Fukuoka University | Method for producing cellulose nanofiber capsule |
CN113797114A (zh) | 2020-06-12 | 2021-12-17 | 玫琳凯有限公司 | 局部用组合物和方法 |
KR102489312B1 (ko) * | 2020-08-13 | 2023-01-17 | 명지대학교 산학협력단 | 상전이 픽커링 에멀젼 및 이의 제조방법 |
DE102020127308A1 (de) | 2020-10-16 | 2022-04-21 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung eingetragener Verein | Kosmetisches Mittel zur Reduktion von Falten |
CN115414262B (zh) * | 2022-07-19 | 2023-09-22 | 江苏诺兴生物科技有限公司 | 一种ε-聚赖氨酸Pickering乳液及其制备方法和用途 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3330730A (en) * | 1962-08-03 | 1967-07-11 | Colgate Palmolive Co | Pressurized emulsion quick breaking foam compositions |
US4515810A (en) * | 1983-10-06 | 1985-05-07 | American Cyanamid Company | Composition of matter |
JP3432979B2 (ja) * | 1995-11-17 | 2003-08-04 | 花王株式会社 | 化粧料 |
FR2754451B1 (fr) * | 1996-10-14 | 1998-11-06 | Oreal | Creme auto-moussante |
JPH11222417A (ja) * | 1998-01-30 | 1999-08-17 | Kose Corp | エアゾール型ヘアトリートメント組成物 |
FR2783171B1 (fr) * | 1998-09-16 | 2000-11-17 | Oreal | Emulsion comprenant un compose epaississant hydrophile et un alkylether de polysaccharide, compositions comprenant ladite emulsion, et utilisations |
FR2783159B1 (fr) * | 1998-09-16 | 2000-11-17 | Oreal | Emulsion comprenant un compose epaississant hydrophile et un copolymere epaississant, compositions comprenant ladite emulsion, et utilisations |
DE19842730A1 (de) * | 1998-09-18 | 2000-03-23 | Beiersdorf Ag | Emulgatorfreie feindisperse Systeme vom Typ Öl-in-Wasser und Wasser-in-Öl |
DE10033414B4 (de) * | 2000-07-08 | 2004-02-19 | Wella Aktiengesellschaft | Klares, zweiphasiges, schaumbildendes Aerosol-Haarpflegeprodukt |
DE10148392A1 (de) * | 2001-09-29 | 2003-04-30 | Beiersdorf Ag | Kosmetische Reinigungsschäume |
DE10161171A1 (de) * | 2001-12-13 | 2003-06-18 | Beiersdorf Ag | Talkumhaltige kosmetische Reinigungsemulsionen |
DE10162840A1 (de) * | 2001-12-20 | 2003-07-03 | Beiersdorf Ag | Kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an wasserlöslichen UV-Filtersubstanzen und Benzoxazol-Derivaten |
US6517816B1 (en) * | 2001-12-26 | 2003-02-11 | Avon Products, Inc. | Sunscreen emulsion composition and method of use |
US20030129213A1 (en) * | 2001-12-26 | 2003-07-10 | Gonzalez Anthony D. | Meta-stable insect repellent emulsion composition and method of use |
DE10238649A1 (de) * | 2002-08-23 | 2004-03-11 | Beiersdorf Ag | Dünnflüssige kosmetische oder dermatologische Zubereitungen von Typ Öl-in Wasser |
US7700076B2 (en) * | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
JP2006036763A (ja) * | 2004-06-25 | 2006-02-09 | Kao Corp | 水中油型乳化組成物 |
DE102004039212A1 (de) * | 2004-08-12 | 2006-03-02 | Wacker-Chemie Gmbh | Rheologiesteuerung von Pickering-Emulsion durch Elektrolyte |
KR20070099038A (ko) * | 2005-01-28 | 2007-10-08 | 바스프 악티엔게젤샤프트 | 화장품 제제를 위한 증점제 형태의 수-중-수 에멀젼중합체의 용도 |
DE102005034685A1 (de) * | 2005-07-25 | 2007-02-08 | Langhals, Heinz, Prof. Dr. | Naphthalinamidinimide und Piperazino-Bisimide |
US9089493B2 (en) * | 2005-09-16 | 2015-07-28 | The Procter & Gamble Company | Skin care composition |
-
2007
- 2007-05-10 EP EP07107950A patent/EP1992323B1/de active Active
- 2007-05-10 PL PL07107950T patent/PL1992323T3/pl unknown
- 2007-05-10 AT AT07107950T patent/ATE544441T1/de active
- 2007-05-10 DK DK07107950.3T patent/DK1992323T3/da active
- 2007-05-10 PT PT07107950T patent/PT1992323E/pt unknown
- 2007-05-10 ES ES07107950T patent/ES2382110T3/es active Active
- 2007-05-10 RS RS20120190A patent/RS52336B/en unknown
-
2008
- 2008-05-09 EA EA200971042A patent/EA023887B1/ru not_active IP Right Cessation
- 2008-05-09 WO PCT/EP2008/055760 patent/WO2008138894A2/de active Application Filing
- 2008-05-09 UA UAA200912805A patent/UA98960C2/uk unknown
- 2008-05-09 KR KR1020097025855A patent/KR101604776B1/ko active IP Right Grant
- 2008-05-09 AU AU2008250298A patent/AU2008250298B2/en active Active
- 2008-05-09 CA CA2683869A patent/CA2683869C/en active Active
- 2008-05-09 US US12/599,561 patent/US20100316684A1/en not_active Abandoned
- 2008-05-09 JP JP2010506950A patent/JP2010527332A/ja active Pending
- 2008-05-09 CN CN200880015421.4A patent/CN101677913B/zh active Active
- 2008-05-09 MX MX2009011708A patent/MX2009011708A/es active IP Right Grant
- 2008-05-09 EP EP08759493A patent/EP2155148A2/de not_active Ceased
-
2009
- 2009-05-18 HK HK09104527.5A patent/HK1126126A1/xx unknown
- 2009-10-06 ZA ZA200906927A patent/ZA200906927B/xx unknown
- 2009-11-05 IL IL201972A patent/IL201972A/en not_active IP Right Cessation
-
2010
- 2010-08-10 EC EC2010010396A patent/ECSP10010396A/es unknown
- 2010-08-10 CO CO10098027A patent/CO6361888A2/es active IP Right Grant
-
2012
- 2012-05-02 HR HRP20120371TT patent/HRP20120371T1/hr unknown
-
2017
- 2017-05-03 US US15/585,955 patent/US20180078794A1/en not_active Abandoned
-
2019
- 2019-10-07 US US16/594,233 patent/US20200276458A1/en not_active Abandoned
-
2021
- 2021-07-26 US US17/384,996 patent/US20220193460A1/en not_active Abandoned
Non-Patent Citations (1)
Title |
---|
See references of WO2008138894A2 * |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1992323B1 (de) | Tensidfreie Schaumformulierungen | |
EP2020221B1 (de) | DMS (Derma Membrane Structure) in Schaum-Cremes | |
EP2335675B1 (de) | Emulgatorfreie, Polymer-stabilisierte Schaumformulierungen | |
EP2363108B1 (de) | Schaumformulierungen enthaltend mindestens ein Triterpenoid | |
KR20130051705A (ko) | 유화 안정성이 우수한 수중유형 나노 에멀젼, 이의 제조방법 및 이를 포함하는 화장료 조성물 | |
EP4346770A1 (de) | Zusammensetzungen enthaltend membranbildende substanzen zur herstellung eines pumpschaumes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20091209 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA MK RS |
|
17Q | First examination report despatched |
Effective date: 20100226 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1137948 Country of ref document: HK |
|
RAX | Requested extension states of the european patent have changed |
Extension state: MK Payment date: 20091209 Extension state: RS Payment date: 20091209 Extension state: BA Payment date: 20091209 |
|
APBK | Appeal reference recorded |
Free format text: ORIGINAL CODE: EPIDOSNREFNE |
|
APBN | Date of receipt of notice of appeal recorded |
Free format text: ORIGINAL CODE: EPIDOSNNOA2E |
|
APBR | Date of receipt of statement of grounds of appeal recorded |
Free format text: ORIGINAL CODE: EPIDOSNNOA3E |
|
APAF | Appeal reference modified |
Free format text: ORIGINAL CODE: EPIDOSCREFNE |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R003 |
|
APBT | Appeal procedure closed |
Free format text: ORIGINAL CODE: EPIDOSNNOA9E |
|
APAM | Information on closure of appeal procedure modified |
Free format text: ORIGINAL CODE: EPIDOSCNOA9E |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
18R | Application refused |
Effective date: 20151027 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1137948 Country of ref document: HK |